Multiple comparisons: To compare or not to compare, that is the question

被引:53
作者
Barnett, Mitchell J. [1 ,2 ]
Doroudgar, Shadi [1 ,3 ]
Khosraviani, Vista [1 ]
Ip, Eric J. [1 ,3 ]
机构
[1] Touro Univ, Clin Sci Dept, Calif Coll Pharm, 1310 Club Dr, Vallejo, CA 94592 USA
[2] Iowa Publ Hlth, Board Pharm, Prescript Monitoring Program, 4688 400 SW 8th St E, Des Moines, IA 50309 USA
[3] Stanford Univ, Dept Med Primary Care & Populat Hlth, 1265 Welch Rd, Stanford, CA 94305 USA
关键词
Type-I error; Bonferroni adjustments; Pharmacy research; Methods; ISSUES;
D O I
10.1016/j.sapharm.2021.07.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Researchers attempt to minimize Type-I errors (concluding there is a relationship between variables, when there in fact, isn't one) in their experiments by exerting control over the p-value thresholds or alpha level. If a statistical test is conducted only once in a study, it is indeed possible for the researcher to maintain control, so that the likelihood of a Type-I error is equal to or less than the significance (p-value) level. When making multiple comparisons in a study, however, the likelihood of making a Type-I error can dramatically increase. When conducting multiple comparisons, researchers frequently attempt to control for the increased risk of Type-I errors by making adjustments to their alpha level or significance threshold level. The Bonferroni adjustment is the most common of these types of adjustment. However, these, often rigid adjustments, are not without risk and are often applied arbitrarily. The objective of this review is to provide a balanced commentary on the advantages and disadvantages of making adjustments when undertaking multiple comparisons. A summary discussion of familiar- and experiment-wise error is also presented. Lastly, advice on when researchers should consider making adjustments in p-value thresholds and when they should be avoided, is provided.
引用
收藏
页码:2331 / 2334
页数:4
相关论文
共 18 条
[1]   When to use the Bonferroni correction [J].
Armstrong, Richard A. .
OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2014, 34 (05) :502-508
[2]   Controlling the false discovery rate in behavior genetics research [J].
Benjamini, Y ;
Drai, D ;
Elmer, G ;
Kafkafi, N ;
Golani, I .
BEHAVIOURAL BRAIN RESEARCH, 2001, 125 (1-2) :279-284
[3]   The p-Value Requires Context, Not a Threshold [J].
Betensky, Rebecca A. .
AMERICAN STATISTICIAN, 2019, 73 :115-117
[4]   Editorial: Multiplicity issues in clinical trials [J].
Dmitrienko, Alex ;
D'Agostino, Ralph B., Sr. .
STATISTICS IN MEDICINE, 2017, 36 (28) :4423-4426
[6]   Do multiple outcome measures require p-value adjustment? [J].
Feise R.J. .
BMC Medical Research Methodology, 2 (1) :1-4
[7]   STANDARDIZED REGRESSION-COEFFICIENTS - A FURTHER CRITIQUE AND REVIEW OF SOME ALTERNATIVES [J].
GREENLAND, S ;
MACLURE, M ;
SCHLESSELMAN, JJ ;
POOLE, C ;
MORGENSTERN, H .
EPIDEMIOLOGY, 1991, 2 (05) :387-392
[8]   Statistical analysis for toxicity studies [J].
Hamada, Chikuma .
JOURNAL OF TOXICOLOGIC PATHOLOGY, 2018, 31 (01) :15-22
[9]   The Proposal to Lower P Value Thresholds to .005 [J].
Ioannidis, John P. A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14) :1429-1430
[10]   Statistical Issues in Longitudinal Data Analysis for Treatment Efficacy Studies in the Biomedical Sciences [J].
Liu, Chunyan ;
Cripe-, Timothy P. ;
Kim, Mi-Ok .
MOLECULAR THERAPY, 2010, 18 (09) :1724-1730